Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B

Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients

NCT01487876 ·Status: UNKNOWN ·Phase: PHASE2

Long-Term Lamivudine Therapy for Chronic Hepatitis B

NCT00120354 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients

NCT03244085 ·Status: UNKNOWN ·Phase: PHASE1

Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis

NCT00076336 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

NCT05960240 ·Status: COMPLETED ·Phase: PHASE1

A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects

NCT05569941 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

NCT04248426 ·Status: COMPLETED ·Phase: PHASE1

A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone

NCT00354653 ·Status: COMPLETED ·Phase: PHASE4

A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection

NCT03576066 ·Status: COMPLETED ·Phase: PHASE2

Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials

NCT01438424 ·Status: COMPLETED ·Phase: PHASE2

Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients

NCT01436539 ·Status: UNKNOWN ·Phase: PHASE4

Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients

NCT00316719 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B

NCT00095121 ·Status: COMPLETED ·Phase: PHASE3

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

NCT00013702 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV Infection

NCT04775797 ·Status: TERMINATED ·Phase: PHASE1

A Randomized Controlled Trial of Lamivudine in Acute Hepatitis B

NCT00380614 ·Status: COMPLETED ·Phase: PHASE4

An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options

NCT00042393 ·Status: APPROVED_FOR_MARKETING

Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients

NCT00798460 ·Status: TERMINATED ·Phase: PHASE4

Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection

NCT00362635 ·Status: COMPLETED ·Phase: PHASE3

An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B

NCT00124241 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA

NCT03770624 ·Status: UNKNOWN ·Phase: PHASE1

A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection

NCT00393484 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B

NCT00877149 ·Status: COMPLETED ·Phase: PHASE4

A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection

NCT02826018 ·Status: TERMINATED ·Phase: PHASE1

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection

NCT05414981 ·Status: COMPLETED ·Phase: PHASE1